Inductive Bio has secured up to $21m in funding from ARPA-H to lead the development of AI drug-toxicity prediction models.

Experts said that US public health is now at risk after the CDC vaccine panel voted against the widespread recommendation for the hepatitis B vaccine at birth.

Viatris has signed definitive agreements for the sale of its equity stake in Biocon Biologics to Biocon for $815m.

Agilent Technologies has expanded its collaboration with Monash University Malaysia (MUM) for the establishment of a ...

Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

The UK becomes the latest country in President Donald Trump’s long line of trade agreements, though it is the first region to ...

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

Opinions amongst the CDC's ACIP were divided on the continued use of the hepatitis B vaccine in a paediatric population.

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.